BAI Li, Professor of University of Science and Technology of China
Vice Dean of Institute of Health and Medicine, Hefei Comprehensive National Science Center
TIAN Zhigang, Director of Institute of Immunology, University of Science and Technology of China
Institute of Immunology, University of Science and Technology of China
Director of the Science and Technology Committee and Chief Scientist of Institute of Health and Medicine, Hefei Comprehensive National Science Center
14:35 - 15:00
主题报告
Keynote Speech
多重基因编辑技术创制及通用免疫细胞治疗应用
Development of Multiplex Gene Editing Tools for Universal Immune Cell Therapy
杨辉, 中国科学院上海药物研究所基因治疗中心（筹）主任
YANG Hui, Director of Gene Therapy Center, Shanghai Institute of Materia Medica, Chinese Academy of Sciences
15:00 - 15:25
主题报告
Keynote Speech
CAR-T细胞发展的关键挑战和对策
Key Challenges and Strategies for CAR-T Development
李宗海, 科济药业董事长、CEO
LI Zonghai, Chairman of the Board, CEO of CARsgen Therapeutics
15:25 - 15:50
主题报告
Keynote Speech
技术创新驱动CGT领域价值创造
Driving Value Creation in CGT through Technological Innovation
常楠楠, 高瓴创投董事总经理
CHANG Nannan, Managing Director, GL Ventures
15:50 - 17:00
第二阶段：主题讨论
Session II: Panel
15:50 - 17:00
主题讨论
Panel
CGT创新生态建设与全球竞争力构建
From Innovation Hub to Global Leadership: Building CGT Competitiveness
主持人 Moderator
金结平, 联新资本董事
JIN Jieping, Director of NewAlliance Capital
讨论嘉宾： Panelist:
陈佳, 上海科技大学生命科学与技术学院教授，基因编辑中心主任
CHEN Jia, Tenured Professor and Principal Investigator, School of Life Science and Technology, ShanghaiTech University; Director of the Gene Editing Center
陈健华, 复旦大学附属肿瘤医院大内科副主任
CHEN Jianhua, Deputy Director of the Department of Medical Oncology, Shanghai Cancer Center, Shanghai Medical College, Fudan University
鲁薪安, 北京艺妙神州生物医药股份有限公司创始人&CMO，北京希济生物科技有限公司创始人&CEO
LU Xin'an, Founder & CMO of IMUNOPHARM Technology Co., Ltd.
Founder & CEO of Beijing Cygenta Biotech Co., Ltd.
孙志刚, 恒瑞医药副总裁、首席质量官
SUN Zhigang, Vice President & Chief Quality Officer, Jiangsu Hengrui Pharmaceuticals Co., Ltd.
会议咨询